Brooktree Capital Management Pfizer Inc Transaction History

Brooktree Capital Management

$157 Million
Q3 2025

A detailed history of Brooktree Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Brooktree Capital Management holds 129,646 shares of PFE stock, worth $3.25 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares

129,646

Previous 121,355 6.83%

Holding current value

$3.25 Million

Previous $2.94 Million 12.31%

% of portfolio

2.1%

Previous 1.95%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$23.29 - $25.88 $193,097 - $214,571	8,291 Added 6.83%	129,646 $3.3 Million
Q2 2025 Aug 06, 2025	BUY	$21.59 - $24.84 $68,742 - $79,090	3,184 Added 2.69%	121,355 $2.94 Million
Q1 2025 May 06, 2025	BUY	$25.01 - $27.13 $69,727 - $75,638	2,788 Added 2.42%	118,171 $2.99 Million
Q4 2024 Feb 10, 2025	BUY	$24.8 - $30.19 $34,447 - $41,933	1,389 Added 1.22%	115,383 $3.06 Million
Q3 2024 Nov 06, 2024	BUY	$27.7 - $31.39 $36,453 - $41,309	1,316 Added 1.17%	113,994 $3.3 Million

Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $216,579 - $253,790	-8,574 Reduced 7.07%	112,678 $3.15 Million
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $158,369 - $181,858	6,117 Added 5.31%	121,252 $3.36 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $258,086 - $335,225	-9,877 Reduced 7.9%	115,135 $3.31 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $116,807 - $136,536	3,640 Added 3.0%	125,012 $4.15 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $152,715 - $176,688	-4,228 Reduced 3.37%	121,372 $4.45 Million
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $65,348 - $85,073	-1,659 Reduced 1.3%	125,600 $5.12 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $106,754 - $139,356	-2,557 Reduced 1.97%	127,259 $6.52 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $247,244 - $301,823	5,650 Added 4.55%	129,816 $5.68 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $121,955 - $144,600	2,621 Added 2.16%	124,166 $6.51 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $385,764 - $478,010	8,432 Added 7.45%	121,545 $6.29 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $49,831 - $73,867	-1,206 Reduced 1.05%	113,113 $6.68 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $90,353 - $116,066	2,302 Added 2.06%	114,319 $4.92 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $622,966 - $705,716	17,348 Added 18.32%	112,017 $4.39 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $65,807 - $74,218	1,965 Added 2.12%	94,669 $3.43 Million
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $35,009 - $44,517	-1,046 Reduced 1.12%	92,704 $3.41 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $132,207 - $155,109	4,164 Added 4.65%	93,750 $3.44 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $47,348 - $57,440	1,572 Added 1.79%	89,586 $2.93 Million
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $428,912 - $612,822	15,868 Added 21.99%	88,014 $2.87 Million
Q4 2019 Feb 26, 2020	BUY	$32.92 - $37.36 $2.38 Million - $2.7 Million	72,146 New	72,146 $2.83 Million

Others Institutions Holding PFE

# of Institutions

3,356

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brooktree Capital Management with notifications on news.

Account

Brooktree Capital Management Pfizer Inc Transaction History